Inspire Medical Systems, Inc. Announces Appointment of Ezgi Yagci as Vice President of Investor Relations
15 Agosto 2022 - 9:00AM
Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical
technology company focused on the development and commercialization
of innovative, minimally invasive solutions for patients with
obstructive sleep apnea, today announced the appointment of Ezgi
Yagci as Vice President of Investor Relations, effective August 15,
2022.
"The team is very excited to welcome Ezgi and her vast
experience in the medical technology sector to Inspire,” said Tim
Herbert, President and Chief Executive Officer of Inspire Medical
Systems. “She will have a positive impact on our expanding investor
relations program and play a key role in contributing to the
overall strategy of the organization.”
Ms. Yagci joins Inspire from Zimmer Biomet where she served as
Investor Relations Manager since July 2020. She was responsible for
all aspects of earnings preparation, investment conference
participation, sell side interactions and targeted, proactive
shareholder outreach and engagement. Ms. Yagci was instrumental in
the Environmental, Social and Governance disclosures while
researching, benchmarking and enhancing the company’s annual
sustainability report.
Ms. Yagci has over 15 years of experience as an institutional
investor in medical devices and healthcare services while serving
in senior roles at multiple top-tier investment firms, including
Balyasny Asset Management, Green Arrow Capital Management
(Millennium Management), TIAA-CREF, Partner Fund Management and RS
Investments. She holds both Master's and Bachelor of Arts degrees
in Economics, as well as a Bachelor of Arts in International
Relations, all from Boston University.
“I am thrilled to join the team at Inspire, especially as the
company anticipates important product innovations and enhancements
that will fuel its further growth,” said Ms. Yagci. “I look forward
to contributing to Inspire’s mission of serving the many patients
with untreated OSA.”
About Inspire Medical Systems
Inspire is a medical technology company focused on the
development and commercialization of innovative, minimally invasive
solutions for patients with obstructive sleep apnea. Inspire’s
proprietary Inspire therapy is the first and only FDA-approved
neurostimulation technology that provides a safe and effective
treatment for moderate to severe obstructive sleep apnea.
For additional information about Inspire, please visit
www.inspiresleep.com.
Forward Looking Statements
This press release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of
1995. All statements other than statements of historical facts are
forward-looking statements. In some cases, you can identify
forward-looking statements by terms such as ‘‘may,’’ ‘‘will,’’
‘‘should,’’ ‘‘expect,’’ ‘‘plan,’’ ‘‘anticipate,’’ ‘‘could,’’
“future,” “outlook,” “guidance,” ‘‘intend,’’ ‘‘target,’’
‘‘project,’’ ‘‘contemplate,’’ ‘‘believe,’’ ‘‘estimate,’’
‘‘predict,’’ ‘‘potential,’’ ‘‘continue,’’ or the negative of these
terms or other similar expressions, although not all
forward-looking statements contain these words.
These forward-looking statements are based on management’s
current expectations and involve known and unknown risks and
uncertainties that may cause our actual results, performance or
achievements to be materially different from any future results,
performance or achievements expressed or implied by the
forward-looking statements, including those found under the
captions “Risk Factors” and "Management's Discussion and Analysis
of Financial Condition and Results of Operations“ in our Annual
Report on Form 10-K for the fiscal year ended December 31, 2021, as
updated in our Quarterly Report on Form 10-Q for the quarter ended
June 30, 2022, and as such factors may be updated from time to time
in our other filings with the SEC, which are accessible on the
SEC’s website at www.sec.gov and the Investors page of our website
at www.inspiresleep.com. These and other important factors could
cause actual results to differ materially from those indicated by
the forward-looking statements made in this press release. Any such
forward-looking statements represent management’s estimates as of
the date of this press release. While we may elect to update such
forward-looking statements at some point in the future, unless
required by applicable law, we disclaim any obligation to do so,
even if subsequent events cause our views to change. Thus, one
should not assume that our silence over time means that actual
events are bearing out as expressed or implied in such
forward-looking statements. These forward-looking statements should
not be relied upon as representing our views as of any date
subsequent to the date of this press release.
Investor & Media Contact:Ezgi YagciInspire
Medical Systems, Inc.ezgiyagci@inspiresleep.com(617)
549-2443
Inspire Medical Systems (NYSE:INSP)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Inspire Medical Systems (NYSE:INSP)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024